Related Experiment Video
Updated: Aug 11, 2026

Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
Published on: December 4, 2017
ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade
W H Baricos1, S L Cortez, S S el-Dahr
1Department of Biochemistry, Tulane Medical School, New Orleans, Louisiana, USA.
Abstract:
We examined the role of the plasminogen activator/plasmin system in extracellular matrix (ECM) degradation by human mesangial cells cultured on thin films of 125I-labeled ECM (Matrigel). ECM degradation (release of 125I into the medium) was dependent on exogenous plasminogen, proportional to the number of mesangial cells and amount of plasminogen added, and coincident with the appearance of plasmin in the medium. ECM degradation was completely blocked (P < 0.001) by two plasmin inhibitors, alpha-2-antiplasmin (40 micrograms/ml) and aprotinin (216 KIU/ml), and partially reduced (-33 +/- 1.8%, P < 0.01) by TIMP-1 (40 micrograms/ml), a specific inhibitor of matrix metalloproteinases. Zymography of medium obtained from cells cultured in the absence of plasminogen revealed the presence of latent matrix metalloproteinase-2 (MMP-2) which was converted to a lower molecular weight, active form in the presence of mesangial cells and plasminogen. Northern analysis of poly A+RNA prepared from cultured human mesangial cells revealed mRNA for tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor-1 (PAI-1), and uPA receptor (uPAR). The presence of uPA protein in medium obtained from cultured human mesangial cells was demonstrated by Western blotting and ELISA which revealed a large molar excess of PAI-1 (1.2 +/- 0.1 x 10(-9) M) over uPA (1.2 +/- 0.1 x 10(-12) M) and tPA (0.19 +/- 0.04 x 10(-9) M). ECM degradation was reduced by a monoclonal antibody (MAb) against human tPA (-54 +/- 8.6%) or human uPA (-39 +/- 5.2%) compared to cells treated with identical amounts of non-specific monoclonal IgG (P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Human mesangial cells degrade extracellular matrix via the plasminogen activator/plasmin system. Inhibiting plasmin and matrix metalloproteinases (MMPs) blocks this degradation, highlighting the system's crucial role.
Area of Science:
- Cell Biology
- Biochemistry
- Extracellular Matrix Research
Background:
- The plasminogen activator/plasmin system is implicated in extracellular matrix (ECM) remodeling.
- Human mesangial cells play a role in kidney function and ECM dynamics.
Purpose of the Study:
- To investigate the involvement of the plasminogen activator/plasmin system in ECM degradation by human mesangial cells.
- To identify the specific components and mechanisms by which mesangial cells degrade ECM.
Main Methods:
- Culturing human mesangial cells on 125I-labeled ECM (Matrigel) to quantify degradation.
- Utilizing plasmin inhibitors (alpha-2-antiplasmin, aprotinin) and an MMP inhibitor (TIMP-1).
- Employing zymography, Northern analysis, Western blotting, and ELISA to detect enzyme activity and expression of key proteins (tPA, uPA, PAI-1, uPAR, MMP-2).
Main Results:
- ECM degradation was dependent on plasminogen and mesangial cell presence, correlating with plasmin appearance.
- Plasmin inhibitors completely blocked degradation, while TIMP-1 partially reduced it.
- Latent MMP-2 was activated in the presence of mesangial cells and plasminogen.
- Mesangial cells express mRNA for tPA, uPA, PAI-1, and uPAR, with excess PAI-1 over uPA and tPA proteins.
- Monoclonal antibodies against tPA and uPA significantly reduced ECM degradation.
Conclusions:
- The plasminogen activator/plasmin system, particularly plasmin, is a key mediator of ECM degradation by human mesangial cells.
- Both plasmin and matrix metalloproteinases (MMPs) contribute to ECM breakdown, with plasmin playing a dominant role.
- Human mesangial cells actively regulate ECM degradation through the expression of plasminogen activators and inhibitors.
Related Concept Videos
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Role of Matrix Metalloproteases in Degradation of ECM
A...
Overview of Cell-Matrix Interactions
Extracellular Matrix

